CVE Vulnerability

CVE-2018-14786

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

7.5 /10

CVSS v2.0 :

V3 Legend

Vector :

Exploitability : 10 / Impact : 6.4

Attack Vector

Attack Complexity

Privileges Required

User Interaction

Confidentiality Impact PARTIAL

Integrity Impact PARTIAL

Availability Impact PARTIAL

Scope

9.4 /10

CVSS v3.0 : CRITICAL

V3 Legend

Vector :

Exploitability : 3.9 / Impact : 5.5

Attack Vector NETWORK

Attack Complexity LOW

Privileges Required NONE

User Interaction NONE

Confidentiality Impact LOW

Integrity Impact HIGH

Availability Impact HIGH

Scope UNCHANGED

References
Link Resource
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 Third Party Advisory US Government Resource
http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states Vendor Advisory
http://www.securityfocus.com/bid/105147 Third Party Advisory VDB Entry
Configurations

Configuration 1
Information

Published : 2018-08-23 07:29

Updated : 2020-08-24 05:37

NVD link : CVE-2018-14786

Mitre link : CVE-2018-14786

Products Affected
No products.
CWE
CWE-287